Stock Information
Nurix Therapeutics Inc (NRIX)
Ticker Symbol: NRIX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,674.28 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -3.45
Revenue (TTM): $0.33 M
Dividend Yield: N/A
ROE: -76.09%
Latest News
-
Oppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $32
Tue, Oct 13, 2026 9:26 AM
-
Truist Securities Maintains Buy on Nurix Therapeutics, Lowers Price Target to $33
Tue, Oct 13, 2026 8:48 AM
-
Baird Maintains Outperform on Nurix Therapeutics, Raises Price Target to $36
Tue, Oct 13, 2026 7:48 AM
-
Needham Reiterates Buy on Nurix Therapeutics, Maintains $34 Price Target
Tue, Oct 13, 2026 6:24 AM
-
Nurix Therapeutics falls 2% following Q3 earnings as operating expenses up
Mon, Oct 12, 2026 8:59 PM
-
Nurix Therapeutics, Inc. (NRIX) Q3 Earnings and Revenues Surpass Estimates
Mon, Oct 12, 2026 8:25 PM
-
Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Mon, Oct 12, 2026 8:05 PM
-
CORRECTION: Nurix Therapeutics Q3 EPS $4.73 Beats $3.98 Estimate, Sales $673.064M Beat $411.481M Estimate
Mon, Oct 12, 2026 4:09 PM
-
10 Health Care Stocks With Whale Alerts In Today’s Session
Mon, Oct 12, 2026 1:35 PM
-
Stock Market: Will S&P 500 Open Up or Down Today?
Thu, Oct 8, 2026 2:12 AM
Key Financials
Financial data not available
